Загрузка...
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer
<p>Abstract</p> <p>Background</p> <p>The human epidermal growth factor receptor 2 (HER2) and p53 pathways may be involved in chemotherapy sensitivity and/or resistance. We explore the value of HER2 and p53 status to foretell docetaxel sensitivity in advanced breast canc...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2011-04-01
|
| Серии: | Journal of Experimental & Clinical Cancer Research |
| Online-ссылка: | http://www.jeccr.com/content/30/1/38 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|